Northwestern Medicine scientists have uncovered key details about a group of rare but serious blood disorders, which may help inform potential treatments, according to a study published in the Journal ...

J&J JNJ announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended granting label expansion ...

A combination featuring Exelixis’ experimental drug zanzalintinib has beaten Bayer’s gastrointestinal cancer med Stivarga in ...

Scientists have developed a tool that can predict how bowel cancer adapts to treatment—helping researchers to design new ...

A study found another potential benefit of the weight loss drugs: lowered risk of chronic conditions. GLP-1 agonist medications such as Ozempic and Wegovy are in high demand, largely due to their ...

It comes amid a rise in bowel cancer striking people in their 20s, 30s and 40s -a phenomenon that has baffled doctors around ...

New data from GoodRx Research reveals just how inadequate and restrictive prescription insurance has become. Medicaid, often ...